World's Best Scientists 2026 revealed!
Stephen J. Peroutka

Stephen J. Peroutka

D-Index & Metrics

Neuroscience

D-Index
67
Citations
17867
World Ranking
2869
National Ranking
1332

Overview

Stephen J. Peroutka is affiliated with Stanford University in the United States and has a publication record focused on Medicine, with particular emphasis on subfields such as Economics and Econometrics, Public Health, Environmental and Occupational Health, Psychiatry and Mental Health, Cellular and Molecular Neuroscience, and Physiology.

Their recent research outputs cover various topics related to health systems, clinical research ethics, dementia and cognitive impairment, receptor mechanisms, neuroscience, and pharmaceutical economics and policy.

Frequent topics of their work include:

  • Health Systems, Economic Evaluations, Quality of Life
  • Ethics in Clinical Research
  • Dementia and Cognitive Impairment Research
  • Receptor Mechanisms and Signaling
  • Neuroscience and Neuropharmacology Research
  • Neurotransmitter Receptor Influence on Behavior
  • Pharmaceutical Economics and Policy

They have collaborated repeatedly with several co-authors, including Nicholas M. Barnes, Gordon S. Baxter, Joël Bockaert, Theresa A. Branchek, and Amy Butler.

Stephen J. Peroutka's frequent publication venues illustrate the dissemination channels of their work and include:

  • IUPHAR/BPS Guide to Pharmacology CITE
  • Contemporary Clinical Trials Communications
  • The Journal of Prevention of Alzheimer s Disease
  • Contemporary Clinical Trials
  • SSRN Electronic Journal

Highlighted recent papers authored by Stephen J. Peroutka include:

  • "Demographic comparison of subjects in FDA approval trials in the United States to disorder specific demographics using Real World Data," 2024, Contemporary Clinical Trials Communications
  • "Defining demographic cohorts in clinical trial populations using large electronic health records databases," 2022, Contemporary Clinical Trials
  • "Demographic Analysis of Industry-Sponsored Alzheimer's Disease Trial Populations in the United States," 2022, The Journal of Prevention of Alzheimer s Disease
  • "Demographic Comparison of Subjects in Fda Approval Trials in the United States to Disorder Specific Demographics Using Real World Data," 2023, SSRN Electronic Journal
  • "5-Hydroxytryptamine receptors in GtoPdb v.2023.1," 2023, IUPHAR/BPS Guide to Pharmacology CITE

Best Publications

  • Two distinct central serotonin receptors with different physiological functions

    Stephen J. Peroutka;Richard M. Lebovitz;Solomon H. Snyder

  • 5-Hydroxytryptamine receptor subtypes

    Stephen J. Peroutka

  • The effect of systemically administered recombinant human nerve growth factor in healthy human subjects

    Brent G. Petty;David R. Cornblath;Bruce T. Adornato;Vinay Chaudhry

  • Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes

    Richard E. Heuring;Stephen J. Peroutka

  • Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.

    Unknown

  • Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors

    Stephen J. Peroutka

  • Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.

    Stephen J. Peroutka

  • 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization

    Stephen J. Peroutka

  • Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

    Stephen J. Peroutka;Holly Newman;Hilary Harris

  • Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.

    S.J. Peroutka;D.C. U'Prichard;D.A. Greenberg;S.H. Snyder

  • Differential effects of 5-hydroxytryptamine1A selective drugs on the 5-HT behavioral syndrome

    Lisa M. Smith;Stephen J. Peroutka

  • A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors.

    Donna Oksenberg;Scot A. Marsters;Brian F. O'Dowd;Hui Jin

  • 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

    Anne Hamik;Stephen J. Peroutka

  • Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment

    George A. Ricaurte;J. William Langston;J. William Langston;Louise E. Delanney;Ian Irwin

  • Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

    Dennis J. McKenna;Stephen J. Peroutka

  • Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans

    Unknown

  • Antiemetics: neurotransmitter receptor binding predicts therapeutic actions.

    Stephen J. Peroutka;Solomon H. Snyder

  • Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain

    Stephen J. Peroutka;Solomon H. Snyder

  • Characterization of the human 5-hydroxytryptamine1B receptor.

    H. Jin;D. Oksenberg;A. Ashkenazi;S. J. Peroutka

  • Neurotransmitter receptor binding in bovine cerebral microvessels

    Stephen J. Peroutka;Michael A. Moskowitz;Michael A. Moskowitz;John F. Reinhard;Solomon H. Snyder

  • Two distinct effects of 5-hydroxytryptamine on single cortical neurons.

    M. Frances Davies;Rudolph A. Deisz;David A. Prince;Stephen J. Peroutka

  • Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites.

    Stephen J. Peroutka;Bruce G. McCarthy

  • Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes

    D.J. Mckenna;D.B. Repke;L. Lo;S.J. Peroutka

  • 5-Hydroxytryptamine receptors.

    Stephen J. Peroutka

  • 5-Hydroxytryptamine receptor "families".

    Anne W. Schmidt;Stephen J. Peroutka

Frequent Co-Authors

Michael D. Mauk
Michael D. Mauk The University of Texas at Austin
Samuel S.-H. Wang
Samuel S.-H. Wang Princeton University
George A. Ricaurte
George A. Ricaurte Johns Hopkins University School of Medicine
Laurence H. Tecott
Laurence H. Tecott University of California, San Francisco
Roland D. Ciaranello
Roland D. Ciaranello Stanford University
David A. Prince
David A. Prince Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience can open doors to a range of related fields and flexible study options. For those interested in clinical psychology, a psyd online program offers a pathway to become a licensed psychologist, blending research and practical skills.

Individuals seeking to make a difference in family and relationship therapy may consider accelerated mft programs online. These allow you to gain qualifications faster and enter the workforce sooner.

If your goal is to start your career quickly, pursuing an accelerated bachelor's degree can shorten your study time without compromising quality. This is particularly useful for students eager to specialize or pivot careers.

When weighing your options, it’s essential to consider financial outcomes as well. Many neuroscience-related paths connect with some of the highest paying degrees in the world, offering great potential for stable and rewarding careers.

Best Scientists Citing Stephen J. Peroutka

Trending Scientists

Recently Published Articles